MSD OCULUS

2016

2016

MSD

MSD

Innovation

Innovation

AR & VR

AR & VR

2016

MSD

Innovation

AR & VR

Use an innovative way to explain the mode of action of KEYTRUDA to HCPs.

CONTEXT / DEMAND

 

In 2016, MSD launched KEYTRUDA, a new immunotherapy indicated in advanced melanoma. KEYTRUDA works with the patient’s immune system to help fight certain cancers.

Objectives for MSD :

  •  Demonstrate the superiority of the drug
  •  Increase the participation and the impact of Professional Events with Oncologists
  •  Help HCPs explain to their patients how the treatment affects the melanoma

For Patients:

  • Understand their pathology and the way their treatment works in their bodies.

CONTEXT / DEMAND

 

In 2016, MSD launched KEYTRUDA, a new immunotherapy indicated in advanced melanoma. KEYTRUDA works with the patient’s immune system to help fight certain cancers.

Objectives for MSD :

• Demonstrate the superiority of the drug

• Increase the participation and the impact of Professional Events with Oncologists

• Help HCPs explain to their patients how the treatment affects the melanoma

 

For Patients:

• Understand their pathology and the way their treatment works in their bodies.

SOLUTION

 

We created a Virtual Reality experience based on the Oculus Rift technology. Through this immersive experience, HCPs are enrolled in a journey within the human body, through the blood system to finally reach the tumor and understand the way the drug interferes with the melanoma. HCPs discovered this cutting-edge technology attending MSD Professional Events. They were impressed !

SOLUTION

 

We created a Virtual Reality experience based on the Oculus Rift technology. Through this immersive experience, HCPs are enrolled in a journey within the human body, through the blood system to finally reach the tumor and understand the way the drug interferes with the melanoma. HCPs discovered this cutting-edge technology attending MSD Professional Events. They were impressed !

They trusted us and so do we

KEEP IN TOUCH!